TCMP
JNJ icon

Thrive Capital Management (Pennsylvania)’s Johnson & Johnson JNJ Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.71M Buy
26,428
+3,485
+15% +$812K 1.27% 15
2026
Q1 		$5.61M Sell
22,943
-2,809
-11% -$654K 1.23% 17
2025
Q4 		$5.33M Sell
25,752
-3,091
-11% -$611K 1.19% 14
2025
Q3 		$5.35M Buy
28,843
+3,237
+13% +$555K 1.38% 14
2025
Q2 		$3.91M Buy
25,606
+10,396
+68% +$1.6M 1.23% 15
2025
Q1 		$2.52M Sell
15,210
-6,615
-30% -$1.04M 1.51% 9
2024
Q4 		$3.16M Buy
21,825
+5,764
+36% +$893K 1.45% 17
2024
Q3 		$2.6M Sell
16,061
-1,229
-7% -$196K 1.23% 13
2024
Q2 		$2.53M Buy
17,290
+3,722
+27% +$554K 1.15% 14
2024
Q1 		$2.15M Buy
13,568
+6,183
+84% +$984K 1.14% 13
2023
Q4 		$1.16M Buy
7,385
+316
+4% +$48.5K 0.62% 44
2023
Q3 		$1.1M Sell
7,069
-191
-3% -$31.5K 0.61% 44
2023
Q2 		$1.2M Buy
7,260
+798
+12% +$129K 0.69% 44
2023
Q1 		$991K Buy
6,462
+189
+3% +$30.5K 0.63% 44
2022
Q4 		$1.11M Buy
6,273
+620
+11% +$107K 0.72% 38
2022
Q3 		$923K Sell
5,653
-6
-0.1% -$1.01K 0.62% 41
2022
Q2 		$1M Sell
5,659
-356
-6% -$63.4K 0.7% 39
2022
Q1 		$1.07M Sell
6,015
-3,471
-37% -$591K 0.64% 39
2021
Q4 		$1.62M Sell
9,486
-1,704
-15% -$279K 1.06% 21
2021
Q3 		$1.81M Sell
11,190
-451
-4% -$76.9K 1.33% 18
2021
Q2 		$1.92M Buy
11,641
+288
+3% +$47.7K 1.49% 14
2021
Q1 		$1.87M Sell
11,353
-33
-0.3% -$5.34K 1.74% 19
2020
Q4 		$1.79M Buy
+11,386
New +$1.68M 1.91% 19

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s JNJ Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, buying an estimated $812K and bringing the position to 26,428 shares worth $6.71M. The position accounts for 1.27% of the portfolio, ranked #15.

Thrive Capital Management (Pennsylvania) first reported a position in JNJ in Q4 2020 and has held it in 23 quarters since. 4,686 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 26,428 shares of Johnson & Johnson worth $6.71M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 3,485 Johnson & Johnson shares in Q2 2026, an estimated $812K.
  • Johnson & Johnson made up 1.27% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #15 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Johnson & Johnson in Q4 2020 and has held it in 23 quarters since.
  • 4,686 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.